Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Segar JL. Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. Clin Perinatol. 2012;39(1):209–20. https://doi.org/10.1016/j.clp.2011.12.007.
2. Tavakkoli F. Review of the role of spironolactone in the therapy of children. https://www.who.int/selection_medicines/committees/expert/18/applications/paediatric/16_Spironolactone.pdf2011. Accessed 19 May 2020.
3. Stella VJ. Foreword. In: Qiu Y, Chen Y, Zhang GGZ, Yu L, Mantri RV, editors. Developing solid oral dosage forms. 2nd ed. Boston: Academic Press; 2017. p. xv–xvi.
4. Narang AS, Desai D, Badawy S. Physicochemical interactions in solid dosage forms. Pharm Res. 2012;29(10):2635–8. https://doi.org/10.1007/s11095-012-0867-5.
5. Darji MA, Lalge RM, Marathe SP, Mulay TD, Fatima T, Alshammari A, et al. Excipient stability in oral solid dosage forms: a review. AAPS PharmSciTech. 2018;19(1):12–26. https://doi.org/10.1208/s12249-017-0864-4.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献